Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0348321 (
Haemophilus
)
15,372
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Bronchiectasis is a disorder of persistent lung inflammation and recurrent infection, defined by a common pathological end point: irreversible bronchial dilatation arrived at through diverse etiologies. This suggests an interplay between immunogenetic susceptibility, immune dysregulation, bacterial infection, and lung damage. The damaged epithelium impairs mucus removal and facilitates bacterial infection with increased cough, sputum production, and airflow obstruction. Lung infection is caused by respiratory bacterial and fungal pathogens, including Pseudomonas aeruginosa,
Haemophilus
, Aspergillus fumigatus, and nontuberculous mycobacteria. Recent studies have highlighted the relationship between the lung microbiota and microbial-pathogen niches. Disease may result from environments favoring
interleukin-17
-driven neutrophilia. Bronchiectasis may present in autoimmune disease, as well as conditions of immune dysregulation, such as combined variable immune deficiency, transporter associated with antigen processing-deficiency syndrome, and hyperimmunoglobulin E syndrome. Differences in prevalence across geography and ethnicity implicate an etiological mix of genetics and environment underpinning susceptibility.
...
PMID:Bronchiectasis: Current Concepts in Pathogenesis, Immunology, and Microbiology. 2698 Jan 62
A deficiency in signal transducer and activator of transcription 3 (STAT3) is responsible for autosomal dominant hyperimmunoglobulin E syndrome, an immunodeficiency syndrome causing
Staphylococcus aureus
,
Streptococcus pneumonia
,
Haemophilus
influenzae
, and, rarely,
Pseudomonas aeruginosa
and
Aspergillus sp
infections. Currently, intracellular pathogens are not targeted in the management of severe infections. The pathophysiologic mechanism of hyperimmunoglobulin E syndrome immunodeficiency has recently been linked to a disorder in the T helper 17 pathway and disruption of the interleukin -23/
interleukin-17
axis. We report an unusual case of severe pleuropneumopathy by
Ureaplasma urealyticum
in a teenage girl with STAT3-deficient hyperimmunoglobulin E syndrome (STAT3 HIES). A previous case of severe lung infection by
Mycoplasma pneumoniae
has already been described in a STAT3-deficient patient, but
U urealyticum
has never been reported in patients with STAT3 HIES. After a review of the literature, it seems that the specific immunodeficiency pathway of STAT3 HIES exposes STAT3 HIES patients to
Ureaplasma
lung infections because the pathophysiology of STAT3 HIES and
Ureaplasma
is based on STAT3 and T helper 17 cells.
...
PMID:Life-Threatening Pneumopathy and
U urealyticum
in a STAT3-Deficient Hyper-IgE Syndrome Patient. 2856 53
Haemophilus
influenza
e rarely causes pyogenic infections in the female genital tract, and even less commonly does this lead to systemic infections. Novel monoclonal antibody therapies targeting
interleukin-17
may impair mucosal immunity, but increased risk for
H. influenza
e infections has not been documented. Here, we describe a case of
H. influenza
e bacteremia associated with pyosalpinx and hypothesize that immunomodulatory treatment for psoriasis predisposed our patient to this infection.
...
PMID:Breech at the Border: An Atypical Case of Invasive
Haemophilus influenzae
in a Patient on a Novel Immunotherapeutic. 3058 86